Xu X, Wei H, Dong Z, Chen Y, Tian Z
School of Life Sciences, University of Science and Technology of China, 443 Huangshan Road, Hefei, Anhui 230027, China.
Inflamm Res. 2006 Apr;55(4):144-52. doi: 10.1007/s00011-006-0064-2.
Intravenous injection of concanavalin A (Con A) can cause mice to suffer from acute liver failure in a dose dependent manner and little is known about the difference between the high dose and the low dose of Con A regarding the immune response they initiate. The aim of this study was to analyze whether differential effects exist between the low dose and high dose of concanavalin A on the intrahepatic immune system and their importance in the development of liver injury.
A high dose of Con A (15 microg/g) was injected intravenously to induce murine hepatitis. A low dose of Con A (3 microg/g) was injected intravenously 12 h before the injection of the high dose of Con A (15 microg/g). Liver injury was evaluated by serum transaminase assay and H&E staining. Serum cytokine concentrations were determined by enzyme-linked immunosorbent assay (ELISA), intrahepatic cytokine and Fas mRNA levels by reverse transcriptase polymerase chain reaction. Intracellular cytokine expression and FasL expression were analyzed by flow cytometry and Fas protein expression in hepatocytes by Western-blotting. Intrahepatic apoptosis was evaluated by terminal-deoxynucleotidyl transferase mediated nick end labeling (TUNEL).
Low dose Con A injection induced a distinct cytokine expression profile, characterized by a preferentially elevated serum IL-6 at the early stage of stimulation, whereas high dose Con A injection provoked significant elevation of various cytokines involved in Con A-induced hepatitis. Pretreatment with a low, nonhepatoxic dose of Con A (3 microg/g) significantly decreased production of proinflammatory cytokines induced by the high dose Con A (15 microg/g). Furthermore, low dose Con A pretreatment could significantly decrease the serum levels of transaminases and liver necrosis induced by high dose of Con A. The intrahepatic Fas expression was also apparently reduced, accompanied by a decrease in hepatocyte apoptosis.
Low dose Con A stimulation induced a different cytokine profile from high dose Con A stimulation resulting in differential importance in the development of liver injury.
静脉注射伴刀豆球蛋白A(Con A)可使小鼠以剂量依赖性方式发生急性肝衰竭,关于高剂量和低剂量Con A引发的免疫反应差异,人们了解甚少。本研究旨在分析低剂量和高剂量伴刀豆球蛋白A对肝内免疫系统的不同影响及其在肝损伤发展中的重要性。
静脉注射高剂量Con A(15微克/克)以诱导小鼠肝炎。在注射高剂量Con A(15微克/克)前12小时静脉注射低剂量Con A(3微克/克)。通过血清转氨酶测定和苏木精-伊红(H&E)染色评估肝损伤。通过酶联免疫吸附测定(ELISA)测定血清细胞因子浓度,通过逆转录聚合酶链反应测定肝内细胞因子和Fas mRNA水平。通过流式细胞术分析细胞内细胞因子表达和FasL表达,通过蛋白质免疫印迹法分析肝细胞中的Fas蛋白表达。通过末端脱氧核苷酸转移酶介导的缺口末端标记(TUNEL)评估肝内凋亡。
低剂量Con A注射诱导了独特的细胞因子表达谱,其特征是在刺激早期血清IL-6优先升高,而高剂量Con A注射引发了Con A诱导的肝炎中涉及的各种细胞因子的显著升高。用低剂量、无肝毒性的Con A(3微克/克)预处理可显著降低高剂量Con A(15微克/克)诱导的促炎细胞因子的产生。此外,低剂量Con A预处理可显著降低高剂量Con A诱导的血清转氨酶水平和肝坏死。肝内Fas表达也明显降低,同时肝细胞凋亡减少。
低剂量Con A刺激诱导的细胞因子谱与高剂量Con A刺激不同,导致其在肝损伤发展中的重要性存在差异。